Home >  Cardiology MDTV >  Cardiology Shorts >  New Blood Test May...

New Blood Test May Predict Heart Attack and Stroke Risk

By - Dr. Bhumika Maikhuri
Published On 2025-02-17 02:45 GMT   |   Update On 2025-02-17 02:45 GMT
Advertisement
A simple scoring system could improve how doctors prevent heart attacks and strokes by identifying patients most likely to benefit from preventive medications, according to a new study published in circulation research.
The test, called the TRIPLE Score, measures specific proteins on blood platelets along with the patient's age to help doctors make more informed decisions about prescribing blood-thinning medications such as aspirin and clopidogrel.
Advertisement
The test requires only a small blood sample and could be developed into a straightforward tool that any healthcare provider could use, not just specialists. The study team found that their new scoring system successfully identified patients whose blood was more likely to form clots in laboratory tests. The results also aligned with existing risk scores that doctors use to predict a patient's likelihood of having a heart attack in the next 10 years.
The test, which is not yet widely available, is being developed so that it can eventually be used at the point-of-care. This will then be implemented in patient studies to verify that the test can improve their care.
Dr Alexander Bye, lead author of the research at the University of Reading, said: "Around 100,000 heart attacks occur each year in the UK, despite significant progress in preventing them. We must think of smarter ways to use drugs like aspirin if we are going to bring this number down. Our new test will help doctors make sure that patients receive the best treatment and keep their quality of life. Next, we aim to make the test even easier to use by developing a finger prick test, so that it as simple as measuring blood glucose."
Reference: Bye, A. P., Kriek, N., Kempster, C., Dunster, J. L., Mitchell, J. L., Sage, T., ... & Gibbins, J. M. (2025). TRIPLE score: GPVI and CD36 expression predict a prothrombotic platelet function phenotype. Circulation Research.
Full View
Tags:    
Article Source : circulation research

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Bhumika Maikhuri
Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

How COVID-19 Pandemic Increased Mental Health Issues, Malaria, and Heart Disease? Study Sheds Light

Preliminary Study from Karnataka Medical College Reveals High Cardiac Risk Among Adolescents

Are Seed Oils Actually Good for Your Heart and Metabolic Health? Study Sheds Light

Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD

New Study Links Gestational Hypertension to Increased Seizure Risk in Children

Teen Sleep Habits May Predict Heart Health in Adulthood: Research

Study Shows Combination Therapy May Improve Survival in Severe Heart Disease

Intensive Blood Pressure Control Reduces Dementia Risk: Study Finds